Kymera Therapeutics, Inc. (KYMR)
79.55
-1.06
(-1.31%)
USD |
NASDAQ |
May 22, 11:56
Kymera Therapeutics Price : 79.55 for May 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 133.22 |
| Revolution Medicines, Inc. | 155.39 |
| Catalyst Pharmaceuticals, Inc. | 31.30 |
| Regeneron Pharmaceuticals, Inc. | 635.68 |
| AbbVie, Inc. | 217.37 |
Price Related Metrics
| PS Ratio | 137.23 |
| PEG Ratio | -1.464 |
| Price to Book Value | 4.250 |
| Earnings Yield | -4.49% |
| Market Cap | 6.544B |
| PEGY Ratio | -1.464 |